{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:55:21Z","timestamp":1773518121232,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by the Fujian Natural Science Foundation","award":["2024J011425"],"award-info":[{"award-number":["2024J011425"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04872-2","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:11:07Z","timestamp":1773457867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KAT2B-mediated epigenetic suppression of RAD51C enhances olaparib sensitivity in colorectal cancer"],"prefix":"10.1007","volume":"96","author":[{"given":"Xiaoqin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"8","key":"4872_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D\u2019Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, K\u00f6hne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, \u00d6sterlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Ta\u00efeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27(8):1386\u20131422. https:\/\/doi.org\/10.1093\/annonc\/mdw235","journal-title":"Ann Oncol"},{"issue":"6","key":"4872_CR2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","volume":"26","author":"S Arena","year":"2020","unstructured":"Arena S, Corti G, Durinikova E, Montone M, Reilly NM, Russo M, Lorenzato A, Arcella P, Lazzari L, Rospo G, Pagani M, Cancelliere C, Negrino C, Isella C, Bartolini A, Cassingena A, Amatu A, Mauri G, Sartore-Bianchi A, Mittica G, Medico E, Marsoni S, Linnebacher M, Abrignani S, Siena S, Di Nicolantonio F, Bardelli A (2020) A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin. Clin Cancer Res 26(6):1372\u20131384. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2409","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4872_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/bjc.2013.741","volume":"110","author":"CM Phelan","year":"2014","unstructured":"Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, Tung N, Llacuachaqui M, Chornokur G, Ping S, Narod SA, Hereditary Breast Cancer Study Group (2014) Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. Br J Cancer 110(2):530\u2013534. https:\/\/doi.org\/10.1038\/bjc.2013.741","journal-title":"Br J Cancer"},{"issue":"4","key":"4872_CR4","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1016\/j.clcc.2018.06.006","volume":"17","author":"AE Soyano","year":"2018","unstructured":"Soyano AE, Baldeo C, Kasi PM (2018) BRCA Mutation and Its Association With Colorectal Cancer. Clin Colorectal Cancer 17(4):e647\u2013e650. https:\/\/doi.org\/10.1016\/j.clcc.2018.06.006","journal-title":"Clin Colorectal Cancer"},{"key":"4872_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.07.018","volume":"60","author":"H Allgayer","year":"2020","unstructured":"Allgayer H, Leupold JH, Patil N (2020) Defining the Metastasome: Perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences. Semin Cancer Biol 60:1\u201313. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.018","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4872_CR6","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1038\/s41467-018-07041-z","volume":"9","author":"N Ishaque","year":"2018","unstructured":"Ishaque N, Abba ML, Hauser C, Patil N, Paramasivam N, Huebschmann D, Leupold JH, Balasubramanian GP, Kleinheinz K, Toprak UH, Hutter B, Benner A, Shavinskaya A, Zhou C, Gu Z, Kerssemakers J, Marx A, Moniuszko M, Kozlowski M, Reszec J, Niklinski J, Eils J, Schlesner M, Eils R, Brors B, Allgayer H (2018) Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. Nat Commun 9(1):4782. https:\/\/doi.org\/10.1038\/s41467-018-07041-z","journal-title":"Nat Commun"},{"issue":"12","key":"4872_CR7","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1002\/1878-0261.13070","volume":"15","author":"L Marongiu","year":"2021","unstructured":"Marongiu L, Landry J, Rausch T, Abba ML, Delecluse S, Delecluse HJ, Allgayer H (2021) Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors. Mol Oncol 15(12):3363\u20133384. https:\/\/doi.org\/10.1002\/1878-0261.13070","journal-title":"Mol Oncol"},{"issue":"3","key":"4872_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ajhg.2018.01.018","volume":"102","author":"SH AlDubayan","year":"2018","unstructured":"AlDubayan SH, Giannakis M, Moore ND, Han GC, Reardon B, Hamada T, Mu XJ, Nishihara R, Qian Z, Liu L, Yurgelun MB, Syngal S, Garraway LA, Ogino S, Fuchs CS, Van Allen EM (2018) Inherited DNA-Repair Defects in Colorectal Cancer. Am J Hum Genet 102(3):401\u2013414. https:\/\/doi.org\/10.1016\/j.ajhg.2018.01.018","journal-title":"Am J Hum Genet"},{"key":"4872_CR9","doi-asserted-by":"publisher","unstructured":"Heeke AL, Pishvaian MJ, Lynce F, Xiu J, Brody JR, Chen WJ, Baker TM, Marshall JL, Isaacs C (2018) Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. https:\/\/doi.org\/10.1200\/PO.17.00286. JCO Precis Oncol 2018:PO.17.00286","DOI":"10.1200\/PO.17.00286"},{"key":"4872_CR10","doi-asserted-by":"publisher","unstructured":"Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Cancer Genome Atlas Research Network,, Xiao MRJ Jr, Wang Y (2018) C Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23(1):239\u2013254.e6. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.076","DOI":"10.1016\/j.celrep.2018.03.076"},{"issue":"7035","key":"4872_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434(7035):913\u2013917. https:\/\/doi.org\/10.1038\/nature03443","journal-title":"Nature"},{"issue":"3","key":"4872_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","volume":"33","author":"B Kaufman","year":"2015","unstructured":"Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balma\u00f1a J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Steiner M, Loman N, Bowen K, Fielding A, Domchek SM (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation. J Clin Oncol 33(3):244\u2013250. https:\/\/doi.org\/10.1200\/JCO.2014.56.2728","journal-title":"J Clin Oncol"},{"issue":"5","key":"4872_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-018-0009-7","volume":"24","author":"A Tutt","year":"2018","unstructured":"Tutt A, Tovey H, Cheang M, Kernaghan S, Kilburn L, Gazinska P, Owen J, Abraham J, Barrett S, Barrett-Lee P, Brown R, Chan S, Dowsett M, Flanagan JM, Fox L, Grigoriadis A, Gutin A, Harper-Wynne C, Hatton MQ, Hoadley KA, Parikh J, Parker P, Perou CM, Roylance R, Shah V, Shaw A, Smith IE, Timms KM, Wardley AM, Wilson G, Gillett C, Lanchbury JS, Ashworth A, Rahman N, Harries M, Ellis P, Pinder SE, Bliss JM (2018) Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nat Med 24(5):628\u2013637. https:\/\/doi.org\/10.1038\/s41591-018-0009-7","journal-title":"Nat Med"},{"issue":"8","key":"4872_CR14","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00432-018-2666-9","volume":"144","author":"A Kowalewski","year":"2018","unstructured":"Kowalewski A, Szylberg \u0141, Saganek M, Napiontek W, Antosik P, Grzanka D (2018) Emerging strategies in BRCA-positive pancreatic cancer. J Cancer Res Clin Oncol 144(8):1503\u20131507. https:\/\/doi.org\/10.1007\/s00432-018-2666-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"4872_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S2468-1253(17)30012-2","volume":"2","author":"BG Czito","year":"2017","unstructured":"Czito BG, Deming DA, Jameson GS, Mulcahy MF, Vaghefi H, Dudley MW, Holen KD, DeLuca A, Mittapalli RK, Munasinghe W, He L, Zalcberg JR, Ngan SY, Komarnitsky P, Michael M (2017) Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study. Lancet Gastroenterol Hepatol 2(6):418\u2013426. https:\/\/doi.org\/10.1016\/S2468-1253(17)30012-2","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"4872_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41416-018-0343-z","volume":"120","author":"V Gorbunova","year":"2019","unstructured":"Gorbunova V, Beck JT, Hofheinz RD, Garcia-Alfonso P, Nechaeva M, Cubillo Gracian A, Mangel L, Elez Fernandez E, Deming DA, Ramanathan RK, Torres AH, Sullivan D, Luo Y, Berlin JD (2019) A phase 2 randomised study of veliparib plus FOLFIRI\u00b1bevacizumab versus placebo plus FOLFIRI\u00b1bevacizumab in metastatic colorectal cancer. Br J Cancer 120(2):183\u2013189. https:\/\/doi.org\/10.1038\/s41416-018-0343-z","journal-title":"Br J Cancer"},{"issue":"2","key":"4872_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1634\/theoncologist.2015-0319","volume":"21","author":"L Leichman","year":"2016","unstructured":"Leichman L, Groshen S, O\u2019Neil BH, Messersmith W, Berlin J, Chan E, Leichman CG, Cohen SJ, Cohen D, Lenz HJ, Gold P, Boman B, Fielding A, Locker G, Cason RC, Hamilton SR, Hochster HS (2016) Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer. Oncologist 21(2):172\u2013177. https:\/\/doi.org\/10.1634\/theoncologist.2015-0319","journal-title":"Oncologist"},{"issue":"11","key":"4872_CR18","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1002\/cncr.31309","volume":"124","author":"MJ Pishvaian","year":"2018","unstructured":"Pishvaian MJ, Slack RS, Jiang W, He AR, Hwang JJ, Hankin A, Dorsch-Vogel K, Kukadiya D, Weiner LM, Marshall JL, Brody JR (2018) A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer. Cancer 124(11):2337\u20132346. https:\/\/doi.org\/10.1002\/cncr.31309","journal-title":"Cancer"},{"issue":"8","key":"4872_CR19","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3390\/cancers12082054","volume":"12","author":"EK Lee","year":"2020","unstructured":"Lee EK, Matulonis UA (2020) PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies. Cancers (Basel) 12(8):2054. https:\/\/doi.org\/10.3390\/cancers12082054","journal-title":"Cancers (Basel)"},{"issue":"9","key":"4872_CR20","doi-asserted-by":"publisher","first-page":"e1006272","DOI":"10.1371\/journal.pgen.1006272","volume":"12","author":"F Gong","year":"2016","unstructured":"Gong F, Chiu LY, Miller KM (2016) Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer. PLoS Genet 12(9):e1006272. https:\/\/doi.org\/10.1371\/journal.pgen.1006272","journal-title":"PLoS Genet"},{"issue":"3","key":"4872_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/10409238.2019.1620676","volume":"54","author":"JJ Kim","year":"2019","unstructured":"Kim JJ, Lee SY, Miller KM (2019) Preserving genome integrity and function: the DNA damage response and histone modifications. Crit Rev Biochem Mol Biol 54(3):208\u2013241. https:\/\/doi.org\/10.1080\/10409238.2019.1620676","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"8","key":"4872_CR22","doi-asserted-by":"publisher","first-page":"a010207","DOI":"10.1101\/cshperspect.a010207","volume":"5","author":"DM MacAlpine","year":"2013","unstructured":"MacAlpine DM, Almouzni G (2013) Chromatin and DNA replication. Cold Spring Harb Perspect Biol 5(8):a010207. https:\/\/doi.org\/10.1101\/cshperspect.a010207","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6735","key":"4872_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/20974","volume":"399","author":"C Dhalluin","year":"1999","unstructured":"Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399(6735):491\u2013496. https:\/\/doi.org\/10.1038\/20974","journal-title":"Nature"},{"issue":"1","key":"4872_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, Felletar I, Volkmer R, M\u00fcller S, Pawson T, Gingras AC, Arrowsmith CH, Knapp S (2012) Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149(1):214\u2013231. https:\/\/doi.org\/10.1016\/j.cell.2012.02.013","journal-title":"Cell"},{"issue":"3","key":"4872_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccell.2018.01.019","volume":"33","author":"C Sun","year":"2018","unstructured":"Sun C, Yin J, Fang Y, Chen J, Jeong KJ, Chen X, Vellano CP, Ju Z, Zhao W, Zhang D, Lu Y, Meric-Bernstam F, Yap TA, Hattersley M, O\u2019Connor MJ, Chen H, Fawell S, Lin SY, Peng G, Mills GB (2018) BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency. Cancer Cell 33(3):401\u2013416e8. https:\/\/doi.org\/10.1016\/j.ccell.2018.01.019","journal-title":"Cancer Cell"},{"issue":"400","key":"4872_CR26","doi-asserted-by":"publisher","first-page":"eaal1645","DOI":"10.1126\/scitranslmed.aal1645","volume":"9","author":"L Yang","year":"2017","unstructured":"Yang L, Zhang Y, Shan W, Hu Z, Yuan J, Pi J, Wang Y, Fan L, Tang Z, Li C, Hu X, Tanyi JL, Fan Y, Huang Q, Montone K, Dang CV, Zhang L (2017) Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Sci Transl Med 9(400):eaal1645. https:\/\/doi.org\/10.1126\/scitranslmed.aal1645","journal-title":"Sci Transl Med"},{"issue":"23\u201324","key":"4872_CR27","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1101\/gad.331231.119","volume":"33","author":"JJ Kim","year":"2019","unstructured":"Kim JJ, Lee SY, Gong F, Battenhouse AM, Boutz DR, Bashyal A, Refvik ST, Chiang CM, Xhemalce B, Paull TT, Brodbelt JS, Marcotte EM, Miller KM (2019) Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity. Genes Dev 33(23\u201324):1751\u20131774. https:\/\/doi.org\/10.1101\/gad.331231.119","journal-title":"Genes Dev"},{"issue":"2","key":"4872_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.molcel.2018.08.020","volume":"72","author":"T Clouaire","year":"2018","unstructured":"Clouaire T, Rocher V, Lashgari A, Arnould C, Aguirrebengoa M, Biernacka A, Skrzypczak M, Aymard F, Fongang B, Dojer N, Iacovoni JS, Rowicka M, Ginalski K, C\u00f4t\u00e9 J, Legube G (2018) Comprehensive Mapping of Histone Modifications at DNA Double-Strand Breaks Deciphers Repair Pathway Chromatin Signatures. Mol Cell 72(2):250\u2013262e6. https:\/\/doi.org\/10.1016\/j.molcel.2018.08.020","journal-title":"Mol Cell"},{"issue":"9","key":"4872_CR29","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.celrep.2017.08.016","volume":"20","author":"H He","year":"2017","unstructured":"He H, Wang J, Liu T (2017) UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair. Cell Rep 20(9):2010\u20132025. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.016","journal-title":"Cell Rep"},{"issue":"5","key":"4872_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/s0092-8674(00)82001-2","volume":"87","author":"VV Ogryzko","year":"1996","unstructured":"Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87(5):953\u2013959. https:\/\/doi.org\/10.1016\/s0092-8674(00)82001-2","journal-title":"Cell"},{"issue":"9","key":"4872_CR31","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.celrep.2017.08.015","volume":"20","author":"M Zhao","year":"2017","unstructured":"Zhao M, Geng R, Guo X, Yuan R, Zhou X, Zhong Y, Huo Y, Zhou M, Shen Q, Li Y, Zhu W, Wang J (2017) PCAF\/GCN5-Mediated Acetylation of RPA1 Promotes Nucleotide Excision Repair. Cell Rep 20(9):1997\u20132009. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.015","journal-title":"Cell Rep"},{"issue":"1731","key":"4872_CR32","doi-asserted-by":"publisher","first-page":"20160286","DOI":"10.1098\/rstb.2016.0286","volume":"372","author":"LY Chiu","year":"2017","unstructured":"Chiu LY, Gong F, Miller KM (2017) Bromodomain proteins: repairing DNA damage within chromatin. Philos Trans R Soc Lond B Biol Sci 372(1731):20160286. https:\/\/doi.org\/10.1098\/rstb.2016.0286","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"4872_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1101\/gad.252189.114","volume":"29","author":"F Gong","year":"2015","unstructured":"Gong F, Chiu LY, Cox B, Aymard F, Clouaire T, Leung JW, Cammarata M, Perez M, Agarwal P, Brodbelt JS, Legube G, Miller KM (2015) Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. Genes Dev 29(2):197\u2013211. https:\/\/doi.org\/10.1101\/gad.252189.114","journal-title":"Genes Dev"},{"issue":"23","key":"4872_CR34","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.3390\/cancers15235580","volume":"15","author":"S Chen","year":"2023","unstructured":"Chen S, Allgayer H (2023) Epigenetically Downregulated Breast Cancer Gene 2 through Acetyltransferase Lysine Acetyltransferase 2B Increases the Sensitivity of Colorectal Cancer to Olaparib. Cancers (Basel) 15(23):5580. https:\/\/doi.org\/10.3390\/cancers15235580","journal-title":"Cancers (Basel)"},{"issue":"15","key":"4872_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/s0960-9822(00)00610-2","volume":"10","author":"TT Paull","year":"2000","unstructured":"Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10(15):886\u2013895. https:\/\/doi.org\/10.1016\/s0960-9822(00)00610-2","journal-title":"Curr Biol"},{"issue":"3","key":"4872_CR36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","volume":"138","author":"JJ Smith","year":"2010","unstructured":"Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, Coffey RJ, Yeatman TJ, Shyr Y, Beauchamp RD (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138(3):958\u2013968. https:\/\/doi.org\/10.1053\/j.gastro.2009.11.005","journal-title":"Gastroenterology"},{"issue":"6589","key":"4872_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/382319a0","volume":"382","author":"XJ Yang","year":"1996","unstructured":"Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y (1996) A p300\/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382(6589):319\u2013324. https:\/\/doi.org\/10.1038\/382319a0","journal-title":"Nature"},{"issue":"10","key":"4872_CR38","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/cas.15498","volume":"113","author":"H Han","year":"2022","unstructured":"Han H, Zhu W, Lin T, Liu C, Zhai H (2022) N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2B. Cancer Sci 113(10):3390\u20133404. https:\/\/doi.org\/10.1111\/cas.15498","journal-title":"Cancer Sci"},{"issue":"21","key":"4872_CR39","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1161\/CIRCULATIONAHA.120.048845","volume":"143","author":"D Li","year":"2021","unstructured":"Li D, Shao NY, Moonen JR, Zhao Z, Shi M, Otsuki S, Wang L, Nguyen T, Yan E, Marciano DP, Contrepois K, Li CG, Wu JC, Snyder MP, Rabinovitch M (2021) ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension. Circulation 143(21):2074\u20132090. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048845","journal-title":"Circulation"},{"issue":"7","key":"4872_CR40","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41418-017-0041-z","volume":"25","author":"Y Li","year":"2018","unstructured":"Li Y, Guo X, Hu C, Du Y, Guo C, Wang D, Zhao W, Huang G, Li C, Lu Q, Lai R, Xu T, Qi X (2018) Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection. Cell Death Differ 25(7):1304\u20131318. https:\/\/doi.org\/10.1038\/s41418-017-0041-z","journal-title":"Cell Death Differ"},{"issue":"9","key":"4872_CR41","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1093\/nar\/gkx075","volume":"45","author":"A Perearnau","year":"2017","unstructured":"Perearnau A, Orlando S, Islam A, Gallastegui E, Mart\u00ednez J, Jordan A, Bigas A, Aligu\u00e9 R, Pujol MJ, Bachs O (2017) p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes. Nucleic Acids Res 45(9):5086\u20135099. https:\/\/doi.org\/10.1093\/nar\/gkx075","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4872_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molcel.2021.11.015","volume":"82","author":"D Sooraj","year":"2022","unstructured":"Sooraj D, Sun C, Doan A, Garama DJ, Dannappel MV, Zhu D, Chua HK, Mahara S, Wan Hassan WA, Tay YK, Guanizo A, Croagh D, Prodanovic Z, Gough DJ, Wan C, Firestein R (2022) MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. Mol Cell 82(1):123\u2013139e7. https:\/\/doi.org\/10.1016\/j.molcel.2021.11.015","journal-title":"Mol Cell"},{"issue":"7381","key":"4872_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481(7381):287\u2013294. https:\/\/doi.org\/10.1038\/nature10760","journal-title":"Nature"},{"key":"4872_CR44","doi-asserted-by":"publisher","first-page":"564601","DOI":"10.3389\/fcell.2020.564601","volume":"8","author":"M Rose","year":"2020","unstructured":"Rose M, Burgess JT, O\u2019Byrne K, Richard DJ, Bolderson E (2020) PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. Front Cell Dev Biol 8:564601. https:\/\/doi.org\/10.3389\/fcell.2020.564601","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"4872_CR45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/2159-8290.CD-11-0348","volume":"2","author":"YH Ibrahim","year":"2012","unstructured":"Ibrahim YH, Garc\u00eda-Garc\u00eda C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzm\u00e1n M, Grueso J, Rodr\u00edguez O, Calvo MT, Aura C, D\u00edez O, Rubio IT, P\u00e9rez J, Rod\u00f3n J, Cort\u00e9s J, Ellisen LW, Scaltriti M, Baselga J (2012) PI3K inhibition impairs BRCA1\/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discov 2(11):1036\u20131047. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0348","journal-title":"Cancer Discov"},{"issue":"2","key":"4872_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molcel.2020.08.018","volume":"80","author":"JJ Kim","year":"2020","unstructured":"Kim JJ, Lee SY, Choi JH, Woo HG, Xhemalce B, Miller KM (2020) PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells. Mol Cell 80(2):327\u2013344e8. https:\/\/doi.org\/10.1016\/j.molcel.2020.08.018","journal-title":"Mol Cell"},{"issue":"3","key":"4872_CR47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s1097-2765(00)80452-9","volume":"5","author":"OD Lau","year":"2000","unstructured":"Lau OD, Kundu TK, Soccio RE, Ait-Si-Ali S, Khalil EM, Vassilev A, Wolffe AP, Nakatani Y, Roeder RG, Cole PA (2000) HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5(3):589\u2013595. https:\/\/doi.org\/10.1016\/s1097-2765(00)80452-9","journal-title":"Mol Cell"},{"issue":"32","key":"4872_CR48","doi-asserted-by":"publisher","first-page":"33716","DOI":"10.1074\/jbc.M402839200","volume":"279","author":"K Balasubramanyam","year":"2004","unstructured":"Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, Sadhale PP, Kundu TK (2004) Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 279(32):33716\u201333726. https:\/\/doi.org\/10.1074\/jbc.M402839200","journal-title":"J Biol Chem"},{"issue":"10","key":"4872_CR49","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1158\/1535-7163.MCT-05-0135","volume":"4","author":"L Stimson","year":"2005","unstructured":"Stimson L, Rowlands MG, Newbatt YM, Smith NF, Raynaud FI, Rogers P, Bavetsias V, Gorsuch S, Jarman M, Bannister A, Kouzarides T, McDonald E, Workman P, Aherne GW (2005) Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol Cancer Ther 4(10):1521\u20131532. https:\/\/doi.org\/10.1158\/1535-7163.MCT-05-0135","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04872-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:02:10Z","timestamp":1773500530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04872-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4872"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04872-2","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All methods were approved by the Institutional Animal Ethics Committee of Nanjing Hospital Affiliated with Nanjing Medical University. All experiments were performed in accordance with relevant guidelines and regulations (ARRIVE guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare that no Generative AI was used in the creation of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI statement"}}],"article-number":"27"}}